Point72 Middle East Fze Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $930,215 - $1.06 Million	-1,200 Reduced 85.71%	200 $175,000
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $623,205 - $759,933	900 Added 180.0%	1,400 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$700.03 - $830.35 $1.19 Million - $1.41 Million	-1,700 Reduced 77.27%	500 $359,000
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $68,049 - $82,697	-100 Reduced 4.35%	2,200 $1.81 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $1.62 Million - $1.76 Million	2,300 New	2,300 $0

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.